While our updated meta-analysis confirmed a definitive OS advantage, the real-world cohort demonstrated only a numerical trend.
← all excerpts
Efficacy and safety of first-line chemoimmunotherapy versus chemotherapy alone for advanced pulmonary lymphoepithelioma-like carcinoma: a systematic review and real-world cohort study.
1
—
—